点击显示 收起
Abstract |
---|
Top Abstract Introduction Materials and Methods Results Discussion Reerences |
---|
Key Words: hemoglobin scavenger receptor interleukin-10 heme oxygenase-1 antiinflammation
Introduction |
---|
Top Abstract Introduction Materials and Methods Results Discussion References |
---|
After endocytosis of Hb:Hp, the heme subunit of Hb is degraded by the rate-limiting heme oxygenase (HO) enzymes. Two main isoforms of HO have been characterized, with HO-2 being constitutively present under physiological conditions and HO-1 being inducible.7 The breakdown of heme yields biliverdin, free iron, and the carbon monoxide (CO) molecule, which has antiinflammatory and cytoprotective effects.8,9 In macrophages, CO reduces proinflammatory and increases antiinflammatory cytokine secretion in response to lipopolysaccharide via a mitogen-activated protein kinase pathway.10 Interestingly, HO-1 expression is upregulated in macrophages during the resolution phase of inflammation11,12 and also in murine macrophages stimulated by interleukin (IL)-10.13 HO-1–mediated antiinflammatory effects may therefore be closely linked with antiinflammatory pathways stimulated by IL-10, such as the suppression of immune and inflammatory responses in macrophages via diminished antigen-presenting capacity and cytokine synthesis.14–16Indeed, deficiency of HO-1 in both human and gene-targeted mice leads to a marked rise in circulating heme and subsequent oxidative vascular and tissue injury, anemia, and chronic inflammation.17,18
Previous studies have indirectly linked CD163 to antiinflammatory phenomena. Early immunohistological work showed that CD163 expression by macrophages coincided with the late phase of experimental gingivitis.2 CD163 has also been shown to be induced experimentally on a subpopulation of macrophages polarized in response to antiinflammatory factors, such as IL-4, IL-10, and corticosteroids.19–22 Other reports suggest that upregulation of CD163 is associated with the release of unidentified antiinflammatory factors23 and that soluble CD163 once shed from the membrane can inhibit T-lymphocyte proliferation.24 However, no antiinflammatory ligand-receptor-effector pathway has yet been described for CD163.
A recently described skin-blistering model used to study in vivo leukocyte extravasation and cytokine production during tissue inflammation in humans involves the topical application of the vesicant cantharidin to healthy skin.25 Although initially described for the study of the acute phase of inflammation, the technique also allows functional studies to be performed on tissue macrophages isolated from resolving blisters.
Cardiac surgery using cardiopulmonary bypass (CPB) provokes a systemic inflammatory response.26,27 This is mainly triggered by contact activation of blood components on the artificial surfaces of the extracorporeal bypass circuit. Although often remaining subclinical and resolving promptly after CPB, in its most extreme form this inflammatory response is associated with multiple-organ failure and high patient mortality. Hemolysis is a well-recognized consequence of CPB, being triggered by shear stresses generated within the bypass circuit.28,29Reports show that plasma-free Hb rises as high as 50 mg/dL by the end of CPB in association with a fall in Hp. The significance of the CD163 receptor in immunomodulation and clearance of Hb:Hp complexes after CPB, thereby promoting resolution of the inflammatory response and patient recovery, is unknown.
In the present study, we have examined whether Hb:Hp binding to CD163 is linked to antiinflammatory effector pathways. We demonstrate that Hb:Hp binding to CD163 triggers IL-10 and HO-1 induction in human macrophages in vitro and in tissue macrophages ex vivo. Functional CD163 is also expressed on circulating monocytes in vivo after coronary artery bypass graft (CABG) surgery with CPB. This in vivo CD163 expression is associated with HO-1 induction postoperatively. These studies therefore identify novel downstream effector pathways induced by Hb:Hp binding to CD163, which may coordinate hemoglobin catabolism with inflammatory resolution after injury.
Materials and Methods |
---|
Top Abstract Introduction Materials and Methods Results Discussion References |
---|
Monocyte-Macrophage Isolation and In Vitro Culture
Human monocytes were isolated from venous blood using a Dextran/Percoll sedimentation technique as previously described.30 Isolated monocytes were cultured on 24-well plates at 5x106 cells/well in IMEM supplemented with L-glutamine (Invitrogen Ltd), 10% autologous serum, and 100 U/mL of penicillin and streptomycin (Invitrogen Ltd). Cells were incubated for up to 7 days, and growth medium was replenished on days 1 and 3 of culture.
Hb:Hp Treatment of Monocyte-Macrophage Cultures
Hb:Hp complexes were generated by dissolving equimolar amounts of Hb and Hp in growth medium, as previously described.3 Hb, Hp, or Hb:Hp complexes were added at final concentrations of 1 mg/mL, unless otherwise stated, to monocyte-macrophage cultures before incubation for 24 hours and collection of supernatants or cell lysates for IL-10 and HO-1 analysis, respectively. Supernatants and cell lysates were stored in aliquots at -70°C before analysis. In some experiments, anti-CD163 mAbs were added at a final concentration of 20 µg/mL.
Cantharidin-Induced Skin Blisters
To investigate in vivo macrophage CD163 expression and IL-10 production at sites of tissue inflammation in healthy, human volunteers, the vesicant Cantharidin was used topically to induce skin blister formation and leukocyte extravasation as previously described.25 Blister fluid was collected at 16 and 40 hours, corresponding to the proinflammatory and resolving phases of blister formation, respectively. Blister cells were analyzed by 3-color flow cytometry for CD163 and L-selectin expression on CD14+ cells (see below) and by ex vivo culture in the presence of Hb:Hp (1 mg/mL), with or without blocking RM3/1 antibody (20 µg/mL), for 24 hours in Costar 96-well half-area microplates (Corning Inc). IL-10 levels in culture supernatants were corrected for variable monocyte-macrophage content in 16- and 40-hour blisters by expressing IL-10 production in terms of picograms per milliliter generated per 105 CD14+ cells.
Flow Cytometric Analysis
In vitro cultured human monocytes/macrophages were prepared for flow cytometric analysis by detaching adherent monolayers with ice-cold PBS supplemented with 2.5 mmol/L EDTA for 15 minutes, followed by scraping and washing into IMEM growth medium.30 CD163 and L-selectin expression in whole blood was determined using the immunolyse whole-blood lysing technique (Beckman Coulter) as previously described.31 The monocyte population in whole blood was identified by characteristic forward- and side-scatter properties and in cantharidin blister exudate fluid by gating with anti-CD14 antibody in the fluorescent (FL)-3 channel. CD163 and L-selectin expression were measured in the FL-1 and FL-2 channels, respectively. For ligand-binding studies, Hb:Hp complexes were initially FITC conjugated, as previously described,32 before incubating with in vitro differentiated macrophages in 24-well plates at 100 µg/mL for 2 hours in the presence and absence of blocking RM3/1 antibody (20 µg/mL) or control anti-CD64 antibody (20 µg/mL). Flow cytometric analysis was carried out using an EPICS XL-3 cytometer (Beckman Coulter).
CABG
Sixteen patients (11 male, 5 female; age, 47 to 76 years) referred for elective CABG surgery to the Hammersmith Hospital, London, were included in the study. Emergency cases, combined procedures, or redo operations were excluded, and none of the patients had signs of infection preoperatively. All had uncomplicated postoperative recoveries. Regional ethics committee approval for the study protocol was gained, and informed consent was obtained from each subject. All patients underwent a routine surgical procedure using standardized anesthetic and CPB techniques.31 Mean CPB time was 74.8±16.7 minutes.
Ex Vivo Culture of Monocytes From CABG Patients
Blood was collected preoperatively by antecubital fossa venesection and at 24 hours after onset of CPB from the central venous catheter. Blood monocytes were isolated and cultured ex vivo in 24-well plates at 5x106 cells per well using the same procedures as described above. Supernatants and cell lysates were collected and stored at -70°C before IL-10 and HO-1 analysis.
Enzyme-Linked Immunosorbent Assays
IL-10 concentrations in culture supernatants were determined by enzyme-linked immunosorbent assay (ELISA) technique (Duosets; R&D Systems) according to the manufacturer’s recommendations. All samples were measured in duplicate, and results are expressed as mean IL-10 concentrations (pg/mL)±SEM from n=3 experiments. Intracellular HO-1 concentrations in cell lysates were quantified by HO-1–specific ELISA (Stressgen Biotechnologies Corp). Results were normalized with respect to lysate protein content using the Bio-Rad Dc protein assay (Bio-Rad).
HO-1 and HO-2 Western Blot Analysis
Monocytes/macrophages were lysed in buffer containing 1% Triton X-100, 25 mmol/L sodium deoxycholate, 150 mmol/L NaCl, 50 mmol/L Tris, pH 7.4, 4 mmol/L EDTA, 200 µmol/L sodium orthovanadate, 10 mmol/L sodium pyrophosphate, 100 mmol/L sodium fluoride, 1 mmol/L phenylmethysulfonyl fluoride, and 5% protease inhibitor cocktail (Sigma Aldrich). Lysates were subjected to SDS-PAGE on 12.5% gels, and separated proteins were transferred to Immobilon-P membranes (Millipore Corporation). Equal loading of lanes was confirmed by estimation of lysate protein content using the Bio-Rad Dc protein assay (Bio-Rad). Induction of HO-1 was established relative to constitutive expression of the HO-2 isomer by probing blots with polyclonal antibody against HO-1, followed by stripping and reprobing with anti–HO-2. Blots were developed with an enhanced chemiluminescence substrate (Amersham Pharmacia Biotech UK Ltd).
Statistical Analysis
Statistical comparisons between groups were made using an unpaired Student’s t test (GraphPad Prism Software, Inc).
Results |
---|
Top Abstract Introduction Materials and Methods Results Discussion References |
---|
|
To demonstrate that IL-10 induction was mediated via the CD163 receptor, a panel of anti-CD163 antibodies with no previously assigned functional properties was screened for blocking activity. This identified antibody clone RM3/1 as a potent inhibitory antibody, thus confirming that Hb:Hp-induced secretion of IL-10 in macrophages was mediated via CD163 (A). Clone Ki-M8 was a nonblocking antibody, and other clones (5C6-FAT, GHI/61, and Bermac-3) exhibited partial blocking activity. Ki-M8 also possessed agonistic properties and induced significant IL-10 secretion in the absence of the Hb:Hp ligand (B). The RM3/1-blocking antibody was next used to confirm ligand binding of Hb:Hp complexes to CD163 (C). This experiment confirmed that binding of FITC-conjugated Hb:Hp complexes to in vitro differentiated macrophages was blocked by RM3/1 but not by control anti-CD64 antibody.
|
HO-1 Induction in Macrophages by Hb:Hp via an IL-10 Autocrine Mechanism
To investigate whether IL-10 induction attributable to Hb:Hp uptake was linked to other pathways of heme catabolism, intracellular HO-1 protein synthesis was investigated in the presence and absence of blocking antibodies against IL-10. These experiments demonstrated strong induction of HO-1 in macrophages exposed to Hb:Hp in vitro, which was blocked by antibodies against CD163 or IL-10 (). Constitutive levels of HO-2 remained unchanged in the presence or absence of Hb:Hp ligand complexes. Weak induction of HO-1 was also observed in the presence of Hb alone, as previously reported.33,34 Also, considering the capacity of IL-10 to induce CD163 expression,19,20 these experiments therefore identify IL-10 as a link between accelerated Hb:Hp scavenging and HO-1 production in macrophages.
|
IL-10 Induction by Hb:Hp Complexes in Macrophages Isolated From Skin Blisters In Vivo
To extend the physiological relevance of these in vitro observations to tissue macrophages in humans, we investigated CD163 expression and antiinflammatory activity by monocyte-macrophages isolated from cantharidin-induced skin blisters. CD163 expression was measured on CD14+-gated leukocytes recovered from blister fluid at 16 and 40 hours after initiation of the blister response to cantharidin during the acute and resolving phases, respectively. Fewer than 5% of CD14+ cells stained positively for CD163 in whole blood (A) or in 16-hour blister fluid (B). However, most CD14+ cells were CD163+ in 40-hour blister fluid (C). Loss of L-selectin expression on monocyte extravasation provided a marker for blood-blister transmigration, as shown in C.35 To additionally examine the functional role of CD163 in skin inflammation, blister exudate cells were cultured ex vivo in the presence and absence of Hb:Hp or inhibitory RM3/1 antibody. These experiments showed that Hb:Hp stimulated IL-10 from 40-hour blister macrophages (but not 16-hour blister cells) and that this was blocked by anti-CD163 mAb RM3/1 (D). The abolition of IL-10 secretion by RM3/1 strongly suggests that CD163 is the sole scavenging receptor on macrophages for Hb:Hp complexes in this model.
|
IL-10 and HO-1 Induction in Circulating Monocytes From Patients After CABG Surgery on CPB
To examine the role of CD163 in the systemic inflammatory and hemolytic responses after CPB surgery, blood samples were collected from 16 patients undergoing elective CABG operations using CPB. We found that CD163 was significantly upregulated on circulating monocytes at 24 hours after the onset of bypass (B). To examine whether elevated expression of CD163 at 24 hours was linked to antiinflammatory IL-10 and HO-1 effector pathways, monocytes were isolated from three CABG patients and cultured ex vivo for 24 hours in the presence and absence of Hb:Hp or RM3/1 antibody. No detectable IL-10 was induced from monocytes collected preoperatively, whereas exposure to Hb:Hp complexes significantly stimulated CD163-dependent IL-10 secretion from monocytes collected 24 hours postoperatively (2928.45±782.18 pg/mL; C). Immunoblotting furthermore demonstrated that intracellular HO-1 protein was strongly induced by Hb:Hp in 24-hour monocytes but not in preoperative monocytes and that this was ablated by antibody RM3/1 (D). To extend the in vivo relevance of our findings, we examined the presence of HO-1 protein in freshly isolated monocytes from patients undergoing CABG surgery and found a significant induction at 24 and 48 hours after CPB onset (E).
|
Discussion |
---|
Top Abstract Introduction Materials and Methods Results Discussion References |
---|
Our studies have also described for the first time an inhibitory anti-CD163 antibody, RM3/1. This antibody is a potent blocker of Hb:Hp complex binding and IL-10 secretion. Previously, only antibody clone EDHU-1 had been assigned functional properties, inasmuch as it was shown to transmit activating signals on cross-linking of CD163.36 Coincidentally, we also identify clone Ki-m8 as an agonistic antibody.
The present communication identifies IL-10 as a new link between HO-1 synthesis in macrophages and Hb:Hp binding via CD163. This link may enable macrophages to coordinate heme scavenging and breakdown with antiinflammatory activity. Thus, not only can cells effectively scavenge and metabolize Hb:Hp complexes from their environment via CD163 and HO-1, they can also exert antiinflammatory and cytoprotective effects via the release of IL-10 and the heme metabolite CO.
The human skin blister data confirm and extend the in vitro monocyte-derived macrophage data in two ways. First, CD163 expression is upregulated on transmigrated monocytes on differentiation into macrophages, and this process occurs more quickly in vivo (relative fluorescent intensity of 32.7 at 40 hours) than in vitro (relative fluorescent intensity of 36.5 at 7 days). Second, CD163+ cells from resolving blisters secrete IL-10 when challenged with Hb:Hp. The appearance of functional CD163 receptors in resolving blisters therefore suggests that antiinflammatory scavenging of Hb:Hp may play a key role in wound healing after trauma or surgery where extravascular hemolysis occurs in wound hematomas.
Interestingly, intimal Hb:Hp scavenging may attenuate the inflammatory mechanisms underlying atherosclerosis. CD163 is expressed on macrophages in atherosclerotic plaques,37 and free Hb, particularly when glycosylated in diabetes, promotes atherogenesis by oxidizing low-density lipoproteins.6,38 Recent epidemiological studies have shown that susceptibility to cardiovascular disease in diabetes is markedly influenced by Hp phenotype and clearance rate of Hb:Hp complexes by CD163.39,40 We suggest that atheroprotection not only depends on the stabilization and removal of pro-oxidant Hb from the vessel wall by Hp and CD163 but also on the subsequent induction of antiinflammatory pathways through IL-10 and HO-1.
Our study reveals for the first time an increase in CD163 expression on circulating human monocytes 24 hours after the onset of CPB surgery, a time when resolution of the inflammatory response to bypass is apparent. Interestingly, this upregulation of CD163 may be linked to a prior surge in plasma IL-10 that we observed at 90 minutes after the onset of CPB (data not shown) and consistent with previous studies.41,42 Also, we demonstrate a significant induction of intracellular HO-1 levels in circulating monocytes 24 to 48 hours after CPB surgery. Based on both the time course of this response and our in vitro findings, it is possible that this occurs secondary to CD163 upregulation and Hb:Hp complex scavenging. Therefore, expression of CD163 and HO-1 on circulating monocytes after CPB may play a dual role in patient recovery after surgery, first, through a direct effect by the endocytic clearance and catabolism of potentially nephrotoxic, proinflammatory free Hb from the circulation, in association with Hp, and, second, through an indirect antiinflammatory effect promoting resolution of the systemic inflammatory response and wound healing. It is possible that clinical outcome after CPB surgery in the future could be improved by manipulation of the inflammatory response before surgery. The principle of such an intervention has already been proven with the demonstration that transplant-associated arteriosclerosis can be ameliorated by prior exposure to CO.43 An approach relevant to CPB might be to prime patients with CABG to express CD163-bearing cells before surgery by administering polarizing cytokines, such as IL-4 or IL-10, or corticosteroids, thus promoting heme catabolism and antiinflammatory wound healing.
In conclusion, we have identified novel antiinflammatory and cytoprotective effector pathways downstream of the hemoglobin scavenger receptor CD163. These pathways may enable CD163+ monocytes/macrophages to effectively ingest and metabolize Hb:Hp complexes from their environment via CD163 and HO-1, respectively, while exerting antiinflammatory and atheroprotective effects via the release of IL-10 and the heme metabolite CO. Hb scavenging may thus act as a molecular switch to promote inflammatory resolution and wound healing, with therapeutic implications for wound healing and the prevention or treatment of atherosclerosis.
Acknowledgments |
---|
References |
---|
Top Abstract Introduction Materials and Methods Results Discussion References |
---|